Research Article

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

Figure 3

Silencing of NLRP3 suppressed cell proliferation and cell cycle progression in DDP-resistant ovarian cancer cells. (a) Both A2780/DDP and SKOV3/DDP cells received transfection using sh-NLRP3-1 and sh-NLRP3 to knock down NLRP3, and the mRNA level of NLRP3 was detected using qRT-PCR. (b) The cell viability was assessed, adopting CCK-8 assay. (c, d) Colony formation assay was conducted to examine cell proliferation. (e, f) Cell cycle was assessed using flow cytometry. , , and .
(a)
(b)
(c)
(d)
(e)
(f)